Stay updated on Pembro and Vorinostat in Stage IV NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembro and Vorinostat in Stage IV NSCLC Clinical Trial page.

Latest updates to the Pembro and Vorinostat in Stage IV NSCLC Clinical Trial page
- Check2 days agoChange DetectedAdded branding references for H. Lee Moffitt Cancer Center and a 'Helpful Links Provided by' section. Removed the NIH operating-status notice from the page.SummaryDifference0.5%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedNo significant changes were detected on the Study Details page for NCT02638090. The content appears unchanged.SummaryDifference0.4%

- Check46 days agoChange DetectedCore page metadata updated: Last Update Posted is now listed as 'Estimated' and Revision upgraded from v3.0.2 to v3.2.0.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page header now shows an estimated last update time and a new revision version v3.1.0, replacing the previous Last Update Posted and Revision: v3.0.2.SummaryDifference0.1%

- Check54 days agoChange DetectedUpdated date references: adds 2025-09-22, 2025-09-18, and a general 2025-09 entry; removes 2025-05-23, 2025-05-21, and May 2025 references.SummaryDifference0.4%

- Check61 days agoChange DetectedRevision: v3.0.2 added (replacing v3.0.1). Back to Top link removed.SummaryDifference0.2%

Stay in the know with updates to Pembro and Vorinostat in Stage IV NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembro and Vorinostat in Stage IV NSCLC Clinical Trial page.